Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands

Mirjam J. Knol, Gertjan H.J. Wagenvoort, Elisabeth A. M. Sanders, Karin Elberse, Bart J. M. Vlaminckx, Hester E. de Melker, Arie van der Ende

Emerging infectious diseases · 2015 · 77 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

Three years after a 7-valent pneumococcal conjugate vaccine was replaced by a 10-valent pneumococcal conjugate vaccine in the Netherlands, we observed a decrease in incidence of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes 1, 5, and 7F. Our data do not support or exclude cross-protection against serotype 19A.

References

9